Krystal Biotech Ownership | Who Owns Krystal Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary


Krystal Biotech is owned by 97.50% institutional investors, 12.30% insiders. Fmr is the largest institutional shareholder, holding 15.14% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.54% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKrystal Biotech97.50%12.30%-9.80%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.28M15.14%$786.67M
Blackrock3.95M13.95%$724.98M
Vanguard group2.87M10.14%$526.89M
Avoro capital advisors2.43M8.60%$446.80M
State street1.33M4.71%$244.77M
Redmile group1.02M3.61%$187.51M
Frazier life sciences management988.46K3.49%$181.52M
Capital world investors878.16K3.10%$161.26M
Price t rowe associates inc /md/600.14K2.12%$110.21M
Dimensional fund advisors lp580.45K2.05%$106.59M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group1.02M11.34%$187.51M
Frazier life sciences management988.46K8.49%$181.52M
S squared85.22K6.91%$15.65M
Avoro capital advisors2.43M5.95%$446.80M
Decheng capital65.77K3.70%$12.08M
First turn management109.22K3.26%$20.06M
Soleus capital management126.00K2.04%$23.14M
Hood river capital management521.09K1.98%$95.69M
Evolutionary tree capital management8.94K1.69%$1.64M
Eam global investors28.84K1.19%$5.30M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Capital world investors878.16K0.03%781.01K
Vanguard group2.87M0.01%436.36K
State street1.33M0.01%388.33K
Ubs asset management americas251.76K0.01%233.50K

Top Sellers

HolderShares% AssetsChange
Redmile group1.02M11.34%-487.17K
Ikarian capital---375.00K
Jennison associates520.39K0.06%-150.34K
Avoro capital advisors2.43M5.95%-122.56K
Lord, abbett392.24K0.23%-99.99K

New Positions

HolderShares% AssetsChangeValue
Eagle asset management76.26K0.07%76.26K$13.90M
Public sector pension investment board54.66K0.06%54.66K$10.04M
Segall bryant & hamill34.74K0.11%34.74K$6.38M
Alps advisors22.27K0.03%22.27K$4.09M
Thrivent financial for lutherans20.63K0.01%20.63K$3.79M

Sold Out

HolderChange
Tfc financial management-1.00
Cibc private wealth group-4.00
Abich financial wealth management-14.00
Itau unibanco-14.00
Innealta capital-14.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202429716.47%27,997,874-1.68%970.98%156-9231.43%
Jun 30, 2024253-28,459,26112.90%1001.17%15518.32%69-19.77%
Mar 31, 202425324.63%25,206,8903.33%921.23%13131.00%8626.47%
Dec 31, 20232032.01%24,393,8192.62%861.09%100-7.41%6823.64%
Sep 30, 20231991.02%23,770,0313.14%891.11%1081.89%55-9.84%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Select Biotechnology1.88M6.54%-
iShares Core S&P Small-Cap ETF1.61M5.60%1.42K
Fidelity Growth Compy Commingled Pl S920.74K3.20%5.31K
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
Vanguard Total Stock Mkt Idx Inv820.96K2.85%-3.76K
American Funds SMALLCAP World A811.71K2.83%-
Fidelity Growth Company Fund679.02K2.36%-1.44K
Vanguard Small Cap Index648.50K2.25%1.25K
iShares Russell 2000 ETF638.22K2.22%-1.43K
SPDR® S&P Biotech ETF505.52K1.76%5.61K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 12, 2024Krishnan Suma President, R&DSell$1.26M
Sep 12, 2024Krishnan Suma President, R&DSell$334.18K
Sep 12, 2024Krishnan Suma President, R&DSell$413.20K
Sep 12, 2024Krishnan Suma President, R&DSell$797.30K
Sep 12, 2024Krishnan Suma President, R&DSell$772.26K

Insider Transactions Trends


DateBuySell
2024 Q3-30
2024 Q2-35
2024 Q1-53
2023 Q4-16
2023 Q3-20

KRYS Ownership FAQ


Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 97.50%, followed by 12.30% insiders and -9.80% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 44.97%, which Krystal Biotech exceeds.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.28M shares, 15.14%), Blackrock (3.95M shares, 13.95%), and Vanguard group (2.87M shares, 10.14%). Together, they hold 39.23% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 11.34% of its assets in 1.02M Krystal Biotech shares, valued at 187.51M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.54% of its total shares outstanding invested in 1.88M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools